Protara Therapeutics, Inc. (TARA) insider trading.
In Q3 2026, insiders at Protara Therapeutics, Inc. reported 6 non-derivative transactions on 1 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $882K.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 1
- Net shares, P minus S
- -215,687
- Insiders
- 1
- Last filed
- 2026-07-01
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Shefferman Jesse | Director, Officer · CEO and President | 6 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | Shefferman Jesse | G (D) | 4,000 | $0 | 696,832 | Form 4 |
| 2026-06-30 | Shefferman Jesse | G (D) | 5,000 | $0 | 691,832 | Form 4 |
| 2026-06-30 | Shefferman Jesse | G (D) | 7,000 | $0 | 700,832 | Form 4 |
| 2026-06-30 | Shefferman Jesse | G (D) | 14,000 | $0 | 707,832 | Form 4 |
| 2026-06-29 | Shefferman Jesse | M (A) | 215,687 | $1.91 | 937,519 | Form 4 |
| 2026-06-29 | Shefferman Jesse | S (D) | 215,687 | $4.09 | 721,832 | Form 4 |
Transaction codes in this quarter
Get TARA insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1359931&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · TARA company page · Protara Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Protara Therapeutics, Inc. (TARA)?
In Q3 2026, insiders at Protara Therapeutics, Inc. reported 6 non-derivative transactions on 1 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $882K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Protara Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/tara.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.